Search Within

Qing Ye

  1. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (9)
Groups
  1. Breast Medicine Service (21)
  2. Department of Medicine (21)
  3. GSK Faculty (21)
  4. Genitourinary Oncology Service (21)
  5. Human Oncology and Pathogenesis Program (21)
  6. Molecular Pharmacology and Chemistry Program Faculty (21)

More Groups

People
  1. David Solit (21)
  2. Neal Rosen (21)
  3. Qing-Bai She (10)
  4. Ayana Sawai (6)
  5. Sarat Chandarlapaty (4)
  6. Yuhong She (4)

More People

Years
  1. 2012 (1)
  2. 2010 (2)
  3. 2009 (1)
  4. 2008 (3)
  5. 2007 (2)
  6. 2006 (6)

More Years

Publications
  1. Cancer Research (8)
  2. EJC Supplements (3)
  3. Cancer Cell (2)
  4. Clinical Cancer Research (2)
  5. Journal of Clinical Oncology (2)
  6. Proceedings of the National Academy of Sciences of the United States of America (2)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. Pergamon-Elsevier Science Ltd (3)
  3. American Society of Clinical Oncology (2)
  4. Cell Press (2)
  5. National Academy of Sciences (2)
  6. Nature Publishing Group (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined inhibition of PI3K/AKT and MAPK signaling is required to inhibit translational initiation and to induce apoptosis in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Inhibition of Hsp90 function downregulates EGFR and sensitizes EGFR-mutant xenografts to paclitaxel
    Meeting Abstract

    Sawai, A.; Greulich, H.; Ye, Q.; Sellers, W.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • BRAF mutation predicts sensitivity to MEK inhibition
    Journal Article

    Solit, D. B.; Garraway, L. A.; Pratilas, C. A.; Sawai, A.; Getz, G.; Basso, A.; Ye, Q.; Lobo, J. M.; She, Y.; Osman, I.; more...
    Nature (2006)

    Fulltext@MSK | Save
  • V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
    Journal Article

    Grbovic, O. M.; Basso, A. D.; Sawai, A.; Ye, Q.; Friedlander, P.; Solit, D.; Rosen, N.
    Proceedings of the National Academy of Sciences of the United States of America (2006)

    Fulltext@MSK | Save
  • Combined inhibition of PI3 kinase and EGFR overcomes the intrinsic apoptosis resistance of PTEN-null cancer cells and suppresses their xenograft growth
    Meeting Abstract

    She, Q. B.; Solit, D.; Ye, Q.; O'reilly, K.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The MEK inhibitor PD0325901 completely inhibits the growth of melanoma tumors with mutationally activated B-Raf
    Meeting Abstract

    Pratilas, C.; Sawai, A.; Ye, Q.; Lobo, J.; She, Y.; Sebolt-Leopold, J.; Rosen, N.; Solit, D.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of p13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y. H.; Solit, D.; Gibbons, J.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
    Journal Article

    She, Qing Bai; Solit, David B.; Ye, Qing; O'reilly, Kathryn E; Lobo, Jose; Rosen, Neal
    Cancer Cell (2005)

    Fulltext@MSK | Save
  • Restoration of PTEN-expression in tumor cells causes them to depend on EGFR for suppression
    Meeting Abstract

    She, Q.; Moasser, M. M.; Ye, Q.; O'reilly, K.; Solit, D.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save